Provider P68-19 Radiation Oncology Program Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program - Opens in a new window Read More - Opens in a new window
Provider QP73-19 Vendor Engagement to Improve Provider Directory Accuracy - Opens in a new window Read More - Opens in a new window
Provider QP74-19 Post Service Claim Appeals - Opens in a new window Read More - Opens in a new window
Provider QP71-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Vascepa - Opens in a new window Read More - Opens in a new window
Provider QP70-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Antifungal Agents - Opens in a new window Read More - Opens in a new window
Provider QP69-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Riluzole - Opens in a new window Read More - Opens in a new window
Provider QP72-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia VIII and IX Extended Half-Life Products - Opens in a new window Read More - Opens in a new window
Provider P54-19 Precertification for Commercial Inpatient Admissions Effective September 1, 2019 - Opens in a new window Read More - Opens in a new window
Provider P54R1-19 Update: Precertification for Commercial Inpatient Admissions - Opens in a new window Read More - Opens in a new window